<?xml version="1.0" encoding="UTF-8"?>
<p>These clinical reports provide insights into the complications and challenges faced in treating SARS-CoV-2 infected patients. Patients with pneumonia caused by other respiratory viruses or SARS-CoV-2 pneumonia patients were often prophylactically treated with broad-spectrum antibiotics, in an attempt to reduce the risk of bacterial superinfections. Complications were observed in patients that were not treated with antibiotics. Antibiotic-resistant infections, in particular, nosocomial - hospital-acquired - infections were common for more than one third of ICU patients, posing a threat to disease progression, often resulting in the death of the affected individual (
 <xref rid="B26" ref-type="bibr">26</xref>, 
 <xref rid="B40" ref-type="bibr">40</xref>).
</p>
